aTyr Pharma Inc. (ATYR)
NASDAQ: ATYR
· Real-Time Price · USD
0.85
-0.04 (-4.85%)
At close: Sep 26, 2025, 10:59 AM
-4.85% (1D)
Bid | 0.85 |
Market Cap | 83.05M |
Revenue (ttm) | n/a |
Net Income (ttm) | -66.64M |
EPS (ttm) | -0.79 |
PE Ratio (ttm) | -1.07 |
Forward PE | -1.61 |
Analyst | Hold |
Dividends | n/a |
Ask | 1.05 |
Volume | 6,479,321 |
Avg. Volume (20D) | 9,790,812 |
Open | 0.87 |
Previous Close | 0.89 |
Day's Range | 0.80 - 0.90 |
52-Week Range | 0.80 - 7.29 |
Beta | 1.01 |
Ex-Dividend Date | n/a |
About ATYR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ATYR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ATYR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsaTyr Pharma Inc. is scheduled to release its earnings on
Nov 6, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-83.25%
aTyr Pharma shares are trading lower after the com...
Unlock content with
Pro Subscription
1 week ago
+14.64%
aTyr Pharma shares are trading higher after Cantor Fitzgerald issued a Buy rating on the stock.